CREATE Medicines
Latest round
- Series B
Last raised
- May 2026
Total raised
- $122M
Investors
- 4
About CREATE Medicines
Based in the US, CREATE Medicines, Inc.CREATE Medicines, Inc. was founded in 2019 and is headquartered in Cambridge, US. The company focuses on developing advanced immunotherapy solutions through its proprietary in vivo CAR platform.CREATE Medicines specializes in advanced immunotherapy solutions, focusing on multi-immune programming through its proprietary in vivo CAR (Chimeric Antigen Receptor) platform. The core product offerings include a suite of mRNA-LNP (lipid nanoparticle) CAR therapies that facilitate direct programming of immune cells, specifically T cells, NK cells, and myeloid cells, within the body. These therapies are aimed at addressing medical challenges in oncology, autoimmunity, and fibrosis, with a focus on overcoming barriers associated with solid tumors.CREATE Medicines generates revenue through partnerships, clinical collaborations, and direct engagements with healthcare providers. The transactional model revolves around providing in vivo CAR therapies to clinical trial participants and healthcare partners, which may include customized treatment plans. The company is focusing on expanding its reach into North American and European markets, aiming to enhance collaborations with hospitals and research institutions by the end of 2024.
Who invested in CREATE Medicines
4 investors across 1 round
See all investors in CREATE Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 14, 2026
Amount
$122M
Investors
Questions about CREATE Medicines
Who invested in CREATE Medicines?
CREATE Medicines has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CREATE Medicines raised?
CREATE Medicines has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CREATE Medicines last raise money?
CREATE Medicines's most recent round on record is a Series B, in May 2026.
What does CREATE Medicines do?
Based in the US, CREATE Medicines, Inc.
Where is CREATE Medicines headquartered?
CREATE Medicines is headquartered in Cambridge, US.
Which VCs invest in companies like CREATE Medicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CREATE Medicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like CREATE Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.